ABCB1 and cancer: Specifically, along with overexpression of lysosomal p-glycoproteins, drug-resistant cancer cells, as discussed previously, can also display robust structural support and maintenance of the lysosomal membrane (through overexpression of LAMP proteins) in an effort to circumvent LMP, raising a clinical question pertaining to differential drug dosing based on the heterogeneous molecular signature of each individual tumor.